The global molecular imaging market is projected to register a CAGR of 7.5% in terms of value during the forecast period i.e.

2017–2027 and to be valued at US$ 6,445.8 Mn by 2027.The report "Global Molecular Imaging Market, By Technology (Gamma Camera, SPECT, PET, Magnetic Resonance Spectroscopy, Optical Imaging, and Molecular Ultrasound Imaging), By Application (Cancer, Heart Disease, Brain Disorder, Gastrointestinal Disorder, Lung Disorder, Bone Disorder, and Others), By End User (Hospital, Diagnostic Imaging Centers, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029”Competitive Landscape:The prominent player operating in the global molecular imaging market includes Carestream Health, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd, Hologic, Inc., Siemens AG, Philips Healthcare, Samsung Medison, Shimadzu Corporation, and Toshiba Medical Systems Corporation.Impact of Covid-19 pandemic on marketDue to the outbreak of Covid-19 pandemic globally, imaging modalities is widely preferred by most healthcare professionals as it provides a primary diagnosis in a short time.

The report will account for Covid19 as a key market contributor.Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-724Key Highlights:In April 2020, in response to the need for critical care during the COVID-19 crisis, Carestream Health has increased production of its portable diagnostic imaging systems.

Carestream’s DRX-Revolution Mobile X-ray System and DRX-Revolution Nano Mobile X-ray System bring the X-ray exam to the patient’s bedside, delivering high-quality digital radiography images to healthcare providers in real time to aid in patient diagnosis.On May 2019, GE Healthcare has collaborated with biotechnology company Indi Molecular to develop a diagnostic tool for the clinical management of patients receiving immunotherapy, a type of cancer treatment.Analyst View:Rising incidence of chronic disorders, improved digital platform penetration, and the increased use of molecular imaging in disciplines such as precision medicine the molecular imaging market is projected to register a steady growth.

Furthermore, with the advent of novel imaging agents counting the multimodality reporter genes is anticipated to rise the clinical application of techniques such as targeted molecular ultrasound and optical imaging because of which these segments are predicted to register an impressive CAGR in the coming years.Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-724Key Market Insights from the report:By product type, imaging and diagnostic devices, such as SPECT and PET uses radioisotope tracers in order to achieve improved imaging capabilities and give more specific information about organ function and dysfunction.

This is attributed due to growing prevalence of CVDs, growing number of cardiac implant procedures, increasing number of patient visits to physician offices for diagnosis, and the presence of reimbursement for these procedures across developed markets.By region, North America led the global molecular imaging devices market in terms of revenue share, due to high level of adoption of imaging devices in the healthcare industry.

The global molecular imaging market is projected to be worth USD 10.71 Billion by 2027, according to a current analysis by Emergen Research.

The report includes profiles of major players in the Molecular Imaging market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.Download FREE Sample PDF Copy (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/271The steady Molecular Imaging market share growth can be attributed to a variety of factors and trends in the global Molecular Imaging market currently.

Global Molecular Imaging market revenue growth is supported to a significant extent due to rising focus by major players on product/service expansion into new and untapped domestic markets and rising competition in the market.

Detecting probable warning of cancer symptoms and adopting rapid measures is essential for early disease diagnosis.Top key vendors in Molecular Imaging Market include are:Canon Inc., Digirad Corporation, General Electric Company, PerkinElmer Inc., Siemens Healthineers Inc., Bruker Corporation, Cardinal Health, Thermo Fisher Scientific, Advanced Accelerator Applications, and DDD-Diagnostics A/S, among others.Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies@ https://www.emergenresearch.com/industry-report/molecular-imaging-marketKey Highlights From The ReportIn July 2019, Bruker Corporation made an announcement about the acquisition of PMOD Technologies LLC, with an emphasis on pharmacokinetic modeling and molecular quantification.

Moreover, an MRI deploying contrast dye is the most appropriate brain and spinal cord tumor molecular imaging technique.Diagnostics centers are projected to grow at the fastest rate in the forecast period.

Diagnostic centers are fitted out with the requisite molecular imaging system and specialist staff, as well as healthcare personnel, for assisting in the process of detecting diseases in individuals displaying specific symptoms.Region wise performance of the Molecular Imaging industryAsia Pacific market share contribution to the global Molecular Imaging market is expected to continue to register comparatively faster growth rate than other regional markets between 2020 and 2028.